Liwei Fang, MD
Institute of Hematology & Blood Diseases Hospital, China
2
2
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yang Xiao, MD
Guangzhou General Hospital of Guangzhou Military Command
Shared therapeutic areas:
Xiaoyu Zhu, ph.D
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provicial Hospital)
Shared therapeutic areas:
Michael Craig, MD
West Virginia University
Shared therapeutic areas:
Mitchell S Cairo, MD
New York Medical College
Shared therapeutic areas:
Neal S Young, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Regis Peffault de Latour, MD, PhD
St. Louis Hospital, Haematology Division, Paris
Shared therapeutic areas:
Amy Dezern, MD
The JOhns Hopkins Sydney Kimmel Comprehensive Cancer Center
Shared therapeutic areas:
Regis Peffault de Latour, Prof, MD
Hospital St. Louis, Paris, France
Shared therapeutic areas:
Antonio M Risitano, MD, PhD
Hospital Avellino, Napels, Italy
Shared therapeutic areas:
Robert A Brodsky, MD
The Johns Hopkins University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia
All 2 trials loaded